Mind Cure Announces $10.0 Million Bought Deal Financing

Mind Cure Health (CSE: MCUR) this afternoon revealed that it is conducting a bought deal financing. The company is looking to raise gross proceeds of $10.0 million under the financing, with units being sold at $0.60 per each. The financing is being lead by Canaccord Genuity Corp.

Under the terms of the financing, each unit is to consist of one common share and one half warrant. Each warrant is valid for a period of five years from the date of issuance, with an exercise price of $0.80 per share.

An acceleration clause is also present on the warrant, enabling the company to accelerate the expiry of the warrant if the stock trades above $1.50 for a period of ten days on a volume weight basis. The company will also look to list the warrants on the CSE upon closing of the transaction.

An over-allotment option has also been granted to underwriters, valid for a period of 30 days following the close of the financing.

Net proceeds from the financing are to be used for product research, develop, and expansions, to further the firms tech platform including further development of the iSTRYM platform, marketing, and for working capital and general corporate purposes.

Mind Cure Health last traded at $0.75 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

One Response

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

Mind Cure Announces new CTO, Geoff Belair

This morning Mind Cure Health Inc. (CSE: MCUR) announced the hiring of Geoff Belair as...

Thursday, October 15, 2020, 09:39:12 AM

Mind Cure Announces New Product, Launch Dates For Nootropic Products

Mind Cure Health (CSE: MCUR) this morning announced that it intends to bring a new...

Tuesday, December 29, 2020, 07:14:06 AM

Mindcure Completes Beta Testing, Launches PsyCollage

Mind Cure Health (CSE: MCUR) has completed the beta testing phase for its proprietary bioinformatics...

Tuesday, February 16, 2021, 07:22:53 AM

Mind Cure Health: A Glance At The Latest Additions To The Advisory Team

Over the course of the last two weeks, Mind Cure Health (CSE: MCUR) has slowly...

Sunday, October 11, 2020, 03:47:00 PM

Mind Cure: Mental Health Focused Firm To Commence Trading Monday

Mind Cure Health (CSE: MCUR) is the latest issue to hit the Canadian Securities Exchange...

Sunday, September 20, 2020, 09:00:00 AM